VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014 May 20; 32(15):1563-70.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Benzamides
Chemotherapy, Adjuvant
Chi-Square Distribution
Disease-Free Survival
DNA Mutational Analysis
Double-Blind Method
Exons
Female
Gastrointestinal Stromal Tumors
Genetic Predisposition to Disease
Humans
Imatinib Mesylate
Kaplan-Meier Estimate
Male
Middle Aged
Mitotic Index
Multivariate Analysis
Mutation
Neoplasm Recurrence, Local
Patient Selection
Phenotype
Piperazines
Precision Medicine
Proportional Hazards Models
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-kit
Pyrimidines
Receptor, Platelet-Derived Growth Factor alpha
Risk Factors
Time Factors
Treatment Outcome
Tumor Burden
Young Adult
authors with profiles
SHREYASKUMAR PATEL